Navigation Links
AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy
Date:5/21/2008

AMSTERDAM, The Netherlands, May 22 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from La Sapienza University in Rome, Italy, to their advanced small nuclear RNA (snRNA)-based exon-skipping technology for the treatment of Duchenne muscular dystrophy (DMD). The combination with AMT's proprietary adeno-associated virus (AAV) gene therapy platform potentially makes up a long-term treatment for this seriously debilitating disease with a single administration of the product.

Duchenne Muscular Dystrophy

Duchenne muscular dystrophy, caused by mutations in the dystrophin gene (essential for muscle function) is a severely debilitating neuromuscular disease. It affects young children, is progressive and leads to death in young adulthood. In the USA and Europe about 120,000 people suffer from it. Today, there is no treatment to prevent the fatal outcome.

The group of Prof. Irene Bozzoni at La Sapienza has done seminal work to develop a treatment for DMD. Using adeno-associated viral vectors, AMT's gene therapy platform of choice, and an exon-skipping snRNA program Bozzoni and co-workers demonstrated long term systemic and therapeutic effect in animals after a single administration[1]. One of the important advantages of the Bozzoni technology is that a single systemic delivery of the AAV vector containing the required antisense RNA-coding construct will result in long-term treatment of Duchenne muscular dystrophy.

Formalizing relationship with leading RNA research group of prof. Irene Bozzoni

Ronald Lorijn, CEO of AMT said: "We are very excited to have inlicenced an exciting therapeutic approach, which has shown to provide a life-long cure in rodents suffering from Duchenne's disease. In Duchenne's disease in particular the combined application of snRNA and AAV vectors has shown tremendous promise. Access to La Sapienza's
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmasset Accesses up to $30 Million of Working Capital
2. DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance
3. Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York
4. eResearchTechnology to Present at the FBR 12th Annual Spring Investor Conference on May 28th 2008
5. NASA Nanotechnology-Based Biosensor Helps Detect Biohazards
6. eResearchTechnology Announces Resignation of its CFO
7. American Oriental Bioengineering Forms Science and Technology Advisory Committee
8. Record Venture Capital and Heated Deal Environment Propel Global Biotechnology Industry Forward in 2007
9. Genetic Engineering and Biotechnology News (GEN) Reports on Mass Spec in Drug Discovery
10. Kiwa Bio-Tech in Collaboration Discussions with Beijing Hai Xin Science and Technology Co., Ltd.
11. Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... LEXINGTON, Ky. , Sept. 18, 2014  Neogen ... it has entered into a strategic agreement with Merck ... Heifer Program. The Igenity Dairy Heifer ... producers essential information on the genetic potential of replacement ... after a calf is born, and is an excellent ...
(Date:9/18/2014)... 18, 2014   Sigma-Aldrich Corporation (Nasdaq: ... entered into a new gene editing partnership with ... Core. Under the partnership, Sigma-Aldrich will provide the ... consultation, and dedicated gene editing bioinformaticians. ... research at the U-M Medical School. One initiative ...
(Date:9/18/2014)... group of rare diseases that afflict skeletal growth ... hits at the fetal stage and is caused ... encoding fibroblast growth factor receptor 3 (FGFR3) has ... thanatophoric dysplasia (TD), a skeletal dysplasia that cause ... lethal, and achondroplasia (ACH), which causes stunted growth ...
(Date:9/18/2014)... new microscopy technology that allows them to view ... , Dubbed "Complementation Activated Light Microscopy" (CALM), the ... order of magnitude finer than conventional optical microscopy, ... at the nanometer scale. , In a paper ... , the researchers behind CALM used it to ...
Breaking Biology Technology:Merck Animal Health to market Neogen's dairy genomic program 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 4Researchers use iPS cells to show statin effects on diseased bone 2Researchers use iPS cells to show statin effects on diseased bone 3Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2
... have an intriguing ball-shaped structure that suggests several interesting ... that the passage of electrons through a bucky ball ... the ball around its center of mass. Moreover, since ... been thought that they may be useful as lubricants ...
... Oct. 16 NxStage Medical,Inc. (Nasdaq: NXTM ), ... release its financial results for the third,quarter 2007 on ... markets. NxStage will also host a conference call ... discuss its third quarter 2007 financial results. To,listen to ...
... Joins EntreMed,s Senior Management Team, ROCKVILLE, Md., ... a clinical-stage pharmaceutical company developing,therapeutics for the treatment ... W. Bair, Ph.D. has been appointed its Senior ... been elected an,executive officer of EntreMed by the ...
Cached Biology Technology:Bouncing bucky balls 2NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd 2EntreMed Appoints Senior Vice President of Research and Development 2EntreMed Appoints Senior Vice President of Research and Development 3EntreMed Appoints Senior Vice President of Research and Development 4
(Date:9/18/2014)... University and the Quebec government have discovered microplastics ... Journal of Fisheries and Aquatic Sciences . , ... or industrial cleansers, to which they are commonly ... and buoyancy, they may readily pass through sewage ... in the world,s oceans, but have only recently ...
(Date:9/18/2014)... millions of Americans to undertake jaunts into the countryside each ... longer within a century, according to new research. , Climate ... the United States as summer temperatures linger later into the ... Ecology and Biogeography . For instance, the paper birch ... New Hampshire could change color one to three weeks ...
(Date:9/18/2014)... the first smartphone app that automatically reveals students, ... other words, your smartphone knows your state of ... how that affects you. , The StudentLife app, ... to their academic performance, also may be used ... monitor mental health, trigger intervention and improve productivity ...
Breaking Biology News(10 mins):Microplastic pollution discovered in St. Lawrence River sediments 2Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4
... of information is a basic property of biological systems. ... impulses. Transmission of signals occurs at an ... signaling molecules, which bear a phosphate or a sulfate ... processes are of supreme importance, they have been extensively ...
... given six scientists more freedom to do especially innovative ... be awarded funding under the DFG,s Reinhart Koselleck Projects ... between 500,000 euros and 1.25 million euros for their ... use flexibly over a five-year period. The ...
... 2008)-Baruch Barry Lieber, Ph.D., professor of biomedical engineering at ... of radiology at the University of Miami Miller School ... Institute of Neurological Disorders and Stroke (NINDS), to support ... brain aneurysms., The $1.9 million grant administered over a ...
Cached Biology News:Sulfurous ping-pong in the urinary tract 2Sulfurous ping-pong in the urinary tract 3More freedom to take risks: DFG funds the first Reinhart Koselleck Projects 2More freedom to take risks: DFG funds the first Reinhart Koselleck Projects 3More freedom to take risks: DFG funds the first Reinhart Koselleck Projects 4University of Miami biomedical engineer 2
... 2D polyacrylamide gel electrophoresis (2D-PAGE) with biological ... core technology platform for proteomic analysis. 2D-PAGE ... samples limited only in the dynamic range ... proteins. Quantitative image based analysis of separated ...
... 177 amino acid polypeptide sequence corresponding to ... Produced by activation of a recombinant ... coli periplasm. SPECIFIC ACTIVITY:The specific activity ... mU/mg, where 1 U is the activity ...
Human interferon-beta (IFN-beta). Recognizes amino acids 30-47 of IFN-beta. No cross-reactivity with Human IFN-alpha or IFN-gamma....
Acetate Plate Sealers 100/Box...
Biology Products: